ci 994 has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
tacedinaline: oral cytostatic drug with impressive differential activity against leukemic cells & normal stem-cells
tacedinaline : A benzamide obtained by formal condensation of the carboxy group of 4-acetamidobenzoic acid with one of the amino groups of 1,2-phenylenediamine. An oral cytostatic drug with impressive differential activity against leukemic cells and normal stem-cells. Also used in combination therapy for selected tumors including non-smoll cell lung, pancreatic, breast, and colorectal cancers.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Loprevite, M | 1 |
| Tiseo, M | 1 |
| Grossi, F | 1 |
| Scolaro, T | 1 |
| Semino, C | 1 |
| Pandolfi, A | 1 |
| Favoni, R | 1 |
| Ardizzoni, A | 1 |
| Gridelli, C | 1 |
| Rossi, A | 1 |
| Maione, P | 1 |
1 review available for ci 994 and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
The potential role of histone deacetylase inhibitors in the treatment of non-small-cell lung cancer.
Topics: Animals; Antineoplastic Agents; Benzamides; Butyrates; Carcinoma, Non-Small-Cell Lung; Enzyme Inhibi | 2008 |
1 other study available for ci 994 and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
In vitro study of CI-994, a histone deacetylase inhibitor, in non-small cell lung cancer cell lines.
Topics: Antineoplastic Agents, Phytogenic; Benzamides; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Surv | 2005 |